A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

• Status: Completed
• Trial end date: 2005-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a study to investigate the pharmacokinetics, safety and tolerability of several doses of voriconazole, intravenous and oral suspension formulations, in children

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Voriconazole

Criteria

Inclusion Criteria:

• Children who require a systemic antifungal agent for the prevention of systemic fungal infection

Exclusion Criteria:

• Children who are receiving medications which cannot be taken concomitantly with voriconazole.